Literature DB >> 11777858

Increased levels of lipopolysaccharide binding protein in plasma in children with kawasaki disease.

Seiichiro Takeshita, Hiroshi Tsujimoto, Hiroko Kawase, Youichi Kawamura, Isao Sekine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11777858      PMCID： PMC119868          DOI： 10.1128/cdli.9.1.205-206.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  6 in total

1.  Increased levels of circulating soluble CD14 in Kawasaki disease.

Authors:  S Takeshita; K Nakatani; H Tsujimoto; Y Kawamura; H Kawase; I Sekine
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

Review 2.  CD14 and innate recognition of bacteria.

Authors:  S D Wright
Journal:  J Immunol       Date:  1995-07-01       Impact factor: 5.422

3.  The role of bacterial lipopolysaccharide-bound neutrophils in the pathogenesis of Kawasaki disease.

Authors:  S Takeshita; K Nakatani; H Kawase; S Seki; M Yamamoto; I Sekine; S Yoshioka
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

4.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].

Authors:  T Kawasaki
Journal:  Arerugi       Date:  1967-03

5.  The level of lipopolysaccharide-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome.

Authors:  A Myc; J Buck; J Gonin; B Reynolds; U Hammerling; D Emanuel
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

6.  Lipopolysaccharide (LPS)-binding protein in human serum determines the tumor necrosis factor response of monocytes to LPS.

Authors:  P Gallay; C Barras; P S Tobias; T Calandra; M P Glauser; D Heumann
Journal:  J Infect Dis       Date:  1994-11       Impact factor: 5.226
  6 in total
  4 in total

1.  Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease.

Authors:  Pong Kian Chua; Marian E Melish; Qigui Yu; Richard Yanagihara; Kara S Yamamoto; Vivek R Nerurkar
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

2.  Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein.

Authors:  Maja Pavcnik-Arnol; Sergej Hojker; Metka Derganc
Journal:  Intensive Care Med       Date:  2004-05-04       Impact factor: 17.440

3.  Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children.

Authors:  Maja Pavcnik-Arnol; Sergej Hojker; Metka Derganc
Journal:  Intensive Care Med       Date:  2007-04-05       Impact factor: 17.440

4.  Characterization of the gut microbiota of Kawasaki disease patients by metagenomic analysis.

Authors:  Akiko Kinumaki; Tsuyoshi Sekizuka; Hiromichi Hamada; Kengo Kato; Akifumi Yamashita; Makoto Kuroda
Journal:  Front Microbiol       Date:  2015-08-11       Impact factor: 5.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.